Cargando…

Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration

Ziritaxestat is a novel inhibitor of autotaxin, an enzyme responsible for the production of lysophosphatidic acid, the downstream signaling of which mediates responses to tissue injury and has been implicated in the pathogenesis of fibrotic conditions such as idiopathic pulmonary fibrosis and system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helmer, Eric, Willson, Ashley, Brearley, Christopher, Westerhof, Mark, Delage, Stephane, Shaw, Iain, Cooke, Ray, Sidhu, Sharan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292235/ https://www.ncbi.nlm.nih.gov/pubmed/34633152 http://dx.doi.org/10.1002/cpdd.1021

Ejemplares similares

Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis
por: Taneja, Amit, et al.
Publicado: (2019)

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
por: van der Aar, Ellen, et al.
Publicado: (2019)

Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS‐5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
por: van der Aar, Ellen, et al.
Publicado: (2021)

Drug–drug interaction prediction of ziritaxestat using a physiologically based enzyme and transporter pharmacokinetic network interaction model
por: Perrier, Jeremy, et al.
Publicado: (2023)

Ziritaxestat Drug–Drug Interaction with Oral Contraceptives: Role of SULT1E1 Inhibition
por: Helmer, Eric, et al.
Publicado: (2022)

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
por: Timmis, Helen, et al.
Publicado: (2021)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021)

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)
por: Maher, Toby M, et al.
Publicado: (2019)

Christian Goldbach 1690–1764
por: Juškevič, Adolf P, et al.
Publicado: (1994)

COLLABORATION AGREEMENT No. K 1690
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2009)

Johannes Schmiedt (1623–1690)
por: Pekacka-Falkowska, Katarzyna, et al.
Publicado: (2021)

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
por: Andersen, Lars P. H., et al.
Publicado: (2016)

1690. Oral Fosfomycin for the Treatment of Bacterial Prostatitis
por: Kamath, Meghan, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
por: Namour, Florence, et al.
Publicado: (2015)

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects
por: Namour, Florence, et al.
Publicado: (2016)

GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial
por: Strambu, Irina R., et al.
Publicado: (2023)

Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers
por: Tummala, Raj, et al.
Publicado: (2018)

International Symposium on Huygens Principle: 1690-1990, Theory and Applications
Publicado: (1990)

Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”
por: Namour, Florence
Publicado: (2015)

Pharmacokinetics of Cefozopran by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers
por: Wu, G. L., et al.
Publicado: (2015)

Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers
por: Hodges, Michael R., et al.
Publicado: (2023)

Highly Contiguous Nanopore Genome Assembly of Chlamydomonas reinhardtii CC-1690
por: O’Donnell, Samuel, et al.
Publicado: (2020)

1690. Risk Factors of Invasive Aspergillosis in Systemic Lupus Erythematosus Patients
por: Kunawathanakul, Sithichai, et al.
Publicado: (2019)

Steric trapping reveals a cooperativity network in the intramembrane protease GlpG
por: Guo, Ruiqiong, et al.
Publicado: (2016)

Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770
por: Yeh, Han-I, et al.
Publicado: (2019)

Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers
por: van Rongen, A, et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers
por: Nagelschmitz, J, et al.
Publicado: (2014)

First observation of the $\Xi^{-}\pi^{+}$ decay mode of the $\Xi(1690)^{0}$ hyperon
por: Adamovich, M I, et al.
Publicado: (1998)

First observation of the $\Xi^{-} \pi^{+}$ decay mode of the $\Xi^{0}(1690)$ hyperon
por: Adamovich, M.I., et al.
Publicado: (1997)

Evidence of a large cooling between 1690 and 1740 AD in southern Africa
por: Sundqvist, H. S., et al.
Publicado: (2013)

P1690: NEUTROPHIL EXTRACELLULAR TRAP (NET) LEVELS IN COVID-19 PATIENTS
por: López De Frutos, L., et al.
Publicado: (2022)

Pharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers
por: Cho, Sang-Heon, et al.
Publicado: (2020)

Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers
por: Liu, Jian, et al.
Publicado: (2020)

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies
por: Desrivot, Julie, et al.
Publicado: (2021)

La Ciudad de México en el siglo XVIII (1690-1780) : tres crónicas /
por: Vetancurt, Augustín de, 1620-1700
Publicado: (1990)

Documentos y mapas para la geografía histórica de Orizaba (1690-1800)
por: Lemoine Villicaña, Ernesto
Publicado: (1962)

Esclavos negros en las haciendas azucareras de Córdoba, Veracruz, 1690-1830
por: Naveda Chávez-Hita, Adriana
Publicado: (2008)

Esclavos negros en las haciendas azucareras de Córdoba, Veracruz, 1690-1830 /
por: Naveda Chávez-Hita, Adriana
Publicado: (1987)

1690. Assessing the safety of TP-102 bacteriophage treatment in the management of diabetic foot infections
por: Nir-Paz, Ran, et al.
Publicado: (2022)

The Rhomboid Protease GlpG Promotes the Persistence of Extraintestinal Pathogenic Escherichia coli within the Gut
por: Russell, Colin W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sg6rbhnug9ocgiqp4h8p76uoiv